Newsroom

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Vest U.S. Equity Buffer UCITS ETF - July 15.12.2025 FJUL.LN IE000YJBT6I5 100,002.00 USD 2,662,472.21 26.624  ...

SALT LAKE CITY--(BUSINESS WIRE)--BetterRX, the leader in real-time hospice pharmacy technology, is proud to announce the appointment of Marcus Wilson, R.Ph., as its first Chief Pharmacy Officer. This strategic addition marks a major milestone in the company’s mission to eliminate medication delays and improve care at end of life. Mr. Wilson brings more than 25 years of experience building and scaling pharmacy operations across hospice, long-term care, specialty, and medical-at-home settings. He...

LONDON--(BUSINESS WIRE)--  Ap27 FORM 8.3 IRISH TAKEOVER PANEL OPENING POSITION DISCLOSURE/DEALING DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2022 BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE 1. KEY INFORMATION (a) Full name of discloser Balyasny Asset Management L.P. (b) Owner or controller of interests and short positions disclosed, if different from 1(a) The naming of nominee or vehicle companies is insufficient. For a trust, t...

GURUGRAM, India--(BUSINESS WIRE)--ReNew Energy Global Plc today announced its long-term agreement with Google to enable the development of a new 150 MW solar project in Rajasthan....

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Vest U.S. Equity Buffer UCITS ETF - April 15.12.2025 FAPR.LN IE000WX2HZQ7 150,002.00 USD 3,636,991.78 24.246  ...

BOSTON--(BUSINESS WIRE)--Ayrmid Ltd., la società madre di Gamida Cell Inc., un pioniere nelle terapie cellulari che lavora per trasformare le cellule in potenti terapie e RoslinCT, un'organizzazione di sviluppo e produzione a contratto di terapie cellulari e geniche, oggi hanno annunciato l'espansione della loro collaborazione strategica per includere l'esecuzione di un accordo di fornitura commerciale a supporto della produzione di Omisirge® (omidubicel-onlv). Il testo originale del presente a...

BOSTON--(BUSINESS WIRE)--Ayrmid Ltd., société mère de Gamida Cell Inc., une société pionnière dans le domaine de la thérapie cellulaire qui transforme les cellules en puissants traitements thérapeutiques, et RoslinCT, leader mondial dans le développement et la fabrication sous contrat de thérapies cellulaires et géniques, ont annoncé aujourd’hui l’extension de leur partenariat stratégique afin d’inclure la signature d’un accord d’approvisionnement commercial visant à soutenir la production d’Om...

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Vest U.S. Equity Moderate Buffer UCITS ETF- August 15.12.2025 GAUG LN IE000TGSG3Y5  650,002.00 USD  22,788,322.88   35.059  ...

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Bloomberg Scarce Resources UCTS ETF 15.12.2025 SCAR LN IE000BW2B3J3   25,002.00 USD    670,458.60   26.816  ...

AMSTERDAM--(BUSINESS WIRE)--Vox AI Partners with Adyen to Bring Payments to Drive-Thru Order Terminals...